One small molecule called EHT 1864 has been shown to inhibit both RAC1 and RAC1B with increased potency (IC50 is around 5 μM), but there is limited evidence for use of EHT 1864 in CRC [178]. Here, RAC1 is linked to colorectal carcinoma.